Most Yeast-Targeted Inhibitors Show Limited Activity Against Microsporidian Parasite
Researchers tested 15 inhibitors with defined yeast molecular targets against the microsporidian parasite Nematocida parisii infecting Caenorhabditis elegans, finding that most showed little to no activity. Microsporidia are obligate intracellular parasites that infect a wide range of animals, and budding yeast has historically served as a model for identifying conserved molecular pathways and their inhibitors. The findings suggest that yeast-based drug screening may have limited translational value for microsporidian infections, though tunicamycin emerged as a notable exception and potential research tool.
A study published on bioRxiv tested 15 inhibitors with well-characterized yeast molecular targets against Nematocida parisii, a microsporidian parasite that infects the model organism Caenorhabditis elegans. The majority of compounds showed limited efficacy against N. parisii infection, suggesting that despite evolutionary conservation of certain molecular pathways between yeast and microsporidia, these pathways may not be sufficiently similar—or sufficiently accessible—to be targeted by the same inhibitors. The one standout compound was tunicamycin, an inhibitor associated with endoplasmic reticulum (ER) stress, which did demonstrate activity against the parasite. This positions tunicamycin as a potential tool for investigating ER stress responses in microsporidia, a poorly understood area of microsporidian biology. The broader implication is that yeast-targeted compound libraries may not be a reliable starting point for developing anti-microsporidian therapeutics, and that microsporidian-specific screening approaches may be necessary.
What's missing
It is unclear whether the limited activity reflects poor compound uptake into intracellular parasites, genuine pathway divergence, or other pharmacological factors.
What different sources said
- bioRxivCenter
Most inhibitors with defined yeast targets have limited activity against the microsporidian Nematocida parisii
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.